Bioactive natural compounds against human coronaviruses: a review and perspective

被引:129
作者
Xian, Yanfang [1 ,2 ]
Zhang, Juan [1 ]
Bian, Zhaoxiang [3 ]
Zhou, Hua [4 ]
Zhang, Zhenbiao [1 ]
Lin, Zhixiu [1 ,2 ,5 ]
Xu, Hongxi [4 ,6 ]
机构
[1] Chinese Univ Hong Kong, Sch Chinese Med, Fac Med, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Sch Chinese Med, Brain Res Ctr, Fac Med, Hong Kong, Peoples R China
[3] Hong Kong Baptist Univ, Sch Chinese Med, Ctr Canc & Inflammat Res, Hong Kong, Peoples R China
[4] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Shanghai 201203, Peoples R China
[5] Chinese Univ Hong Kong, Hong Kong Inst Integrat Med, Hong Kong, Peoples R China
[6] Shanghai Univ Tradit Chinese Med, Sch Pharm, Shanghai 201203, Peoples R China
关键词
Natural compounds; Coronavirus; RNA-Virus; MERS-CoV; SARS-CoV; SARS-CoV-2; COVID-19; ACUTE RESPIRATORY SYNDROME; TRADITIONAL CHINESE MEDICINE; PAPAIN-LIKE PROTEASE; ANTI-HIV TRITERPENE; SARS-CORONAVIRUS; ANTIVIRAL ACTIVITY; SPIKE PROTEIN; IN-VITRO; RESVERATROL; VIRUS;
D O I
10.1016/j.apsb.2020.06.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Coronaviruses (CoVs), a family of enveloped positive-sense RNA viruses, are characterized by club-like spikes that project from their surface, unusually large RNA genome, and unique replication capability. CoVs are known to cause various potentially lethal human respiratory infectious diseases, such as severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and the very recent coronavirus disease 2019 (COVID-19) outbreak. Unfortunately, neither drug nor vaccine has yet been approved to date to prevent and treat these diseases caused by CoVs. Therefore, effective prevention and treatment medications against human coronavirus are in urgent need. In the past decades, many natural compounds have been reported to possess multiple biological activities, including antiviral properties. In this article, we provided a comprehensive review on the natural compounds that interfere with the life cycles of SARS and MERS, and discussed their potential use for the treatment of COVID-19. (C) 2020 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.
引用
收藏
页码:1163 / 1174
页数:12
相关论文
共 123 条
[1]   Overexpression of the nucleocapsid protein of Middle East respiratory syndrome coronavirus up-regulates CXCL10 [J].
Aboagye, James Odame ;
Yew, Chow Wenn ;
Ng, Oi-Wing ;
Monteil, Vanessa M. ;
Mirazimi, Ali ;
Tan, Yee-Joo .
BIOSCIENCE REPORTS, 2018, 38
[2]  
[Anonymous], 2019, VIR POL STRUCT, DOI DOI 10.1016/B978-0-12-815422-9.00001-2
[3]  
[Anonymous], 2017, BMC INFECT DIS, DOI DOI 10.1186/S12879-017-2253-8
[4]  
[Anonymous], 2014, BIOSCI TRENDS, DOI DOI 10.5582/BST.8.45
[5]  
[Anonymous], 2005, ANTIVIR RES, DOI DOI 10.1016/J.ANTIVIRAL.2005.07.002
[6]  
[Anonymous], 2006, ADV VIRUS RES, DOI DOI 10.1016/S0065-3527(06)66005-3
[7]  
[Anonymous], 2018, EXP CELL RES, DOI DOI 10.1016/J.YEXCR.2018.05.012
[8]  
[Anonymous], 2008, CELL MOL IMMUNOL
[9]  
[Anonymous], 2016, INT IMMUNOPHARMACOL, DOI DOI 10.1016/J.INTIMP.2016.02.014
[10]  
[Anonymous], 2020, N S ARCH PHARMA 0303, DOI DOI 10.1007/S00210-020-01814-4